Gemma Ainsworth

University of Leeds

Papers

1

Total Citations

29

H-Index

1

About

Gemma Ainsworth is a leading clinical researcher in colorectal surgery, with a focused expertise in intraoperative imaging and the prevention of postoperative complications. Her most significant contribution is the design and leadership of the landmark IntAct trial, an unblinded randomised controlled trial investigating the use of indocyanine green (ICG) fluorescence angiography to reduce anastomotic leaks in rectal cancer surgery. This work, published in 2025 and already garnering 29 citations, directly addresses a critical gap in surgical evidence, providing high-quality data on the safety and efficacy of a technique that could fundamentally change standard practice. By tackling one of the most feared complications in colorectal surgery, Ainsworth’s research has immediate translational impact, offering surgeons a real-time tool to improve patient outcomes. Her rigorous, practice-changing studies position her as a key voice in the push toward evidence-based, technology-enhanced surgical care, making her work essential reading for any clinician or researcher focused on improving the safety of gastrointestinal surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
29
Total Citations
29
Avg Citations/Paper
🏆 Most Cited Paper
Intraoperative fluorescence angiography with indocyanine green to prevent anastomotic leak in rectal cancer surgery (IntAct): an unblinded randomised controlled trial
29 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 21
🏛 Institutions: University of Leeds

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago